(CercleFinance.com) – Theradiag announces that Biosynex has filed a voluntary takeover bid in cash with the Autorité des marchés financiers for the shares of the Company that it does not hold, at a price of 2.30 euros per stock.
This offer represents a premium of 58.62% and 43.79% respectively compared to the closing share price on September 22, 2022 and the volume-weighted average share price for the 60 days preceding the filing of the offer. ‘Offer.
Theradiag’s Board of Directors, meeting on September 22, 2022, unanimously welcomed the proposed Offer by its members,
Biosynex is a shareholder of the Company with 25.07% of the capital and 25.16% of the voting rights.
The listing of Theradiag shares was suspended this Friday, September 23 until further notice.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
